IAPAC mourns the passing of Canadian HIV researcher, Mark A. Wainberg, PhD, who identified lamivudine (3TC) as effective against HIV, fought HIV denialism, advocated global scale-up of antiretroviral therapy, and promoted the right of HIV-vulnerable people to live free of social intolerance. Click here to read IAPAC’s statement.
IAPAC launches Recommendations for the Rapid Expansion of HIV Self-Testing in Fast-Track Cities
IAPAC launched Recommendations for the Rapid Expansion of HIV Self-Testing in Fast-Track Cities during a joint Brazilian National STI, HIV/AIDS & Viral Hepatitis Program – IAPAC meeting of that country’s cities held January 26, 2017, in Brasília. Developed in collaboration with ASLM, the recommendations promote interventions to break down barriers to this testing technology and promote linkage to HIV care and prevention. Click here to access the recommendations.
IAPAC recognizes 150 individuals at 30th anniversary commemoration
IAPAC recognized 150 individuals, 12 posthumously, who have influenced its mission, vision, and programs over the association’s three-decade history. The “IAPAC 150” were announced at IAPAC’s 30th anniversary commemoration, held October 13, 2016, in Geneva. The “IAPAC 150” are a diverse group of global health leaders, clinicians and researchers, public health specialists, and people living with HIV/AIDS and their advocates from within affected communities. Click here to read the “IAPAC 150” announcement press release.
